PMV Pharmaceuticals (PMVP) director receives 42,000 stock options at $1.1900
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
PMV Pharmaceuticals, Inc. director Arnold J. Levine received a grant of stock options covering 42,000 shares of Common Stock at an exercise price of $1.1900 per share. These options expire on June 4, 2036 and vest on the earlier of June 4, 2027 or the issuer's next annual meeting of stockholders, leaving him with 42,000 options following the grant.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
LEVINE ARNOLD J
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 42,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 42,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 42,000 options
Exercise price: $1.1900 per share
Underlying shares: 42,000 shares
+3 more
6 metrics
Options granted
42,000 options
Stock Option (right to buy) grant to director
Exercise price
$1.1900 per share
Exercise price of granted stock options
Underlying shares
42,000 shares
Common Stock underlying the option grant
Options after grant
42,000 options
Total options following transaction
Vesting date
Earlier of June 4, 2027 or next annual meeting
Vesting condition for the option grant
Expiration date
June 4, 2036
Option expiration for the grant
Key Terms
Stock Option (right to buy), Common Stock, vest, annual meeting of stockholders, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
vest financial
"Shares subject to the option vest on the earlier of (i) June 4, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of stockholders financial
"or (ii) the date of the Issuer's next annual meeting of stockholders."
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
FAQ
What did PMV Pharmaceuticals (PMVP) director Arnold J. Levine receive in this Form 4?
Arnold J. Levine received a grant of stock options covering 42,000 shares of PMV Pharmaceuticals Common Stock. The options are a compensation-related award, not an open-market purchase or sale, and give him the right to buy shares at a fixed exercise price.
What is the exercise price of Arnold J. Levine’s PMVP stock options?
The stock options granted to Arnold J. Levine have an exercise price of $1.1900 per share. This means he can buy PMV Pharmaceuticals Common Stock at $1.1900, regardless of future market price, once the options are vested and exercisable.
When do Arnold J. Levine’s PMVP stock options vest?
The options vest on the earlier of June 4, 2027 or the date of PMV Pharmaceuticals’ next annual meeting of stockholders. Vesting determines when he can begin exercising the options to purchase shares at the fixed $1.1900 exercise price.
When do Arnold J. Levine’s PMV Pharmaceuticals stock options expire?
The options expire on June 4, 2036. After this expiration date, Arnold J. Levine will no longer be able to exercise the options to buy PMV Pharmaceuticals Common Stock, even if they have vested and were previously exercisable.